Biotech AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Preventive Treatment of Migraine in Adults August 17, 2023
Biotech IDEAYA Announces First-Patient-In for Company-Sponsored Phase 2 Clinical Trial Evaluating Darovasertib in (Neo)Adjuvant Uveal Melanoma August 16, 2023
Biotech BRAF-Mutant Metastatic Melanoma in 7MM, 2023-2032: Unveiling the Emerging Drugs, Therapies, and Unmet Needs August 16, 2023
Biotech Tetra Pharm Technologies inaugurates new R&D, manufacturing and production facility August 16, 2023
Biotech South Africa Biopharmaceuticals Market Outlook Report 2023-2028: Innovating for Wellness – Industry Focuses on Precision Medicine August 16, 2023
Biotech Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet August 15, 2023
Biotech Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System August 15, 2023